Keywords: spanish, market, grows, economic, slowdown, pharmaceuticals, grew
Spanish market grows in economic slowdown
Article | 20 July 2001
The Spanish pharmaceuticals market grew 11.7% in first-half 2001 to505.65 billion pesetas ($2.60 billion), despite a more general economic slowdown, with the Glaxo ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
